Dr. Anantha Harijith MD

Dr. Anantha K. Harijith is an Associate Professor of Pediatrics at the University of Arizona College of Medicine and a neonatology researcher at University Hospitals Cleveland. His research focuses on neonatal lung diseases, bronchopulmonary dysplasia, asthma, and sepsis-related inflammation. With extensive training in neonatology and clinical pediatrics, Dr. Harijith has contributed to translational studies investigating cellular mechanisms of neonatal respiratory disorders, sphingolipid signaling pathways, and mitochondrial dysfunction in critical illness. He collaborates on both clinical and pre-clinical studies aimed at improving outcomes in premature infants and children with chronic lung disease, publishing widely in respected peer-reviewed journals.

Education details:

• M.D., Medical Degree (Institution not specified in sources)
• MRCP (UK) – Royal College of Physicians, United Kingdom

Professional background:

• Associate Professor of Pediatrics, University of Arizona College of Medicine
• Faculty, Division of Neonatology, University Hospitals Cleveland Medical Center
• Research focus on neonatal lung injury, inflammation, and respiratory biology

Achievements:

• Authored 50+ peer-reviewed publications in neonatology and pediatric lung biology
• Recognized for translational research on bronchopulmonary dysplasia (BPD)
• Active member in pediatric and neonatal research consortia

Current research projects:

• Mechanisms of bronchopulmonary dysplasia in premature infants
• Sphingolipid and lysophosphatidic acid signaling in neonatal lung injury
• Mitochondrial dysfunction and immune dysregulation in neonatal sepsis
• Therapeutic targets in neonatal airway remodeling and inflammation